Staged Versus Simultaneous Bilateral Knee Arthroplasty

Sponsor
Orthopaedic Innovation Centre (Other)
Overall Status
Recruiting
CT.gov ID
NCT03564730
Collaborator
(none)
224
7
2
104.4
32
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to assist surgeons and patients in answering the question "Should I have both knees replaced at the same time, or should I just do one and wait to do the second one?"

Condition or Disease Intervention/Treatment Phase
  • Procedure: Simultaneous Knee Arthroplasty (UKA)
  • Procedure: Staged Knee Arthroplasty (UKA)
N/A

Detailed Description

This is a multi-center randomized controlled trial of 224 patients in order to clearly delineate differences in post-operative outcomes and the trajectory of recovery between simultaneous and staged bilateral KA. The primary outcome measure is difference in generic health related quality of life between the two groups measured 1 year following surgery. Secondary outcome measures include differences in joint specific scores, time off work, satisfaction and costs.

This trial will inform patients and clinicians about differences in recovery, function and efficacy of the procedure to aid in the selection of treatment pathway to best suit the patient.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
224 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients will be randomized to either simultaneous or staged bilateral KA procedures using randomly generated numbers permuted in blocks of 10.Patients will be randomized to either simultaneous or staged bilateral KA procedures using randomly generated numbers permuted in blocks of 10.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Control Trial of Staged Versus Simultaneous Bilateral Total Knee Arthroplasty
Actual Study Start Date :
Mar 19, 2018
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Total Knee Arthroplasty (TKA)

Patient will have complete replacement - Simultaneous vs Staged

Procedure: Simultaneous Knee Arthroplasty (UKA)
Patient will have both knees completed under one anesthetic.

Procedure: Staged Knee Arthroplasty (UKA)
Patient will have knees completed under 2 anesthetics.

Active Comparator: Unicompartmental Knee Arthroplasty (UKA)

Patient will have half-knee replacement (partial) - Simultaneous vs Staged

Procedure: Simultaneous Knee Arthroplasty (UKA)
Patient will have both knees completed under one anesthetic.

Procedure: Staged Knee Arthroplasty (UKA)
Patient will have knees completed under 2 anesthetics.

Outcome Measures

Primary Outcome Measures

  1. Veterans Rand 12-item Health Survey Score (VR-12) [1 Year]

    The VR-12 is a 12-item questionnaire corresponding to eight principal physical and mental health domains including general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy-fatigue, social functioning and mental health; patient-reported.

Secondary Outcome Measures

  1. Joint function (Oxford-12 knee score) [Pre-operative, 6 months, 12 months, 18 months, 24 months]

    The Oxford Knee Score (OKS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option (0-4). A total of the 12 items will indicated the joint function; lower total score = poorer function.

  2. Return to work [Pre-operative, 6 months, 12 months, 18 months, 24 months]

    Assessment of ability to return to work and time away from work following surgery.

  3. Patient satisfaction [6 months, 12 months, 18 months, 24 months]

    Evaluate change in patient-reported satisfaction using a Likaert scale; 1=Very Satisfied to 5=Very Unsatisfied.

  4. Complications [Intraoperative, 6 months, 12 months, 18 months, 24 months]

    Evaluation type and frequency of complication (adverse events).

  5. Hospital stay [Up to 1 week]

    Number of days in hospital

  6. Transfusion rate [Up to 1 week]

    Number of unit transfused during hospital stay.

  7. Costs of knee replacement surgery [Up to 1 week]

    An attempt to calculate costs of surgery using length of stay data to calculate cost between Simultaneous vs Staged procedures. Length of stay will be calculated in days/hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients considering bilateral knee arthroplasty

  • Patients must sign the consent form

  • Patients must be willing to complete the study questionnaires for the duration of the study

Exclusion Criteria:
  • Patients who require simultaneous bilateral knee replacement surgery in order to manage significant bilateral flexion or valgus knee contractures where staged procedures may result in suboptimal outcomes by increasing the risk of post-operative flexion contracture in the "first replaced" knee

  • patients who are unable to complete the questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Calgary Calgary Alberta Canada T2P 3C5
2 Concordia Hospital Winnipeg Manitoba Canada R2K 3S8
3 St. Joseph's - McMaster University Hamilton Ontario Canada L8N 4A6
4 London Health Sciences Centre London Ontario Canada N6A 5W9
5 Ottawa Hospital Research Institute Ottawa Ontario Canada K1H 8L6
6 St. Michael's Hospital Toronto Ontario Canada M5B 1W8
7 McGill University Montréal Quebec Canada H3A 0G4

Sponsors and Collaborators

  • Orthopaedic Innovation Centre

Investigators

  • Principal Investigator: Eric R. Bohm, MD, University of Manitoba

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Orthopaedic Innovation Centre
ClinicalTrials.gov Identifier:
NCT03564730
Other Study ID Numbers:
  • B2017-046
First Posted:
Jun 21, 2018
Last Update Posted:
May 17, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Orthopaedic Innovation Centre
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2022